Key Findings
- Purpose
To describe the use of kyphoplasty for management of vertebral compression fractures and chronic spinal pain in a patient with sickle cell disease (SCD)–associated osteonecrotic spinal pathology. - Population (Model)
Single-patient case report involving a 30-year-old female with homozygous hemoglobin SS (HbSS) presenting with worsening chronic lower back pain, multiple vertebral fractures, and extensive iron deposition identified on MRI and CT imaging. - Headline Result
Following staged kyphoplasty procedures at L3–L5, the patient reported short-term pain reduction within approximately 40 days postoperatively, with pain scores improving from 8/10 to 3/10. Postoperative imaging demonstrated successful cement placement and reduced fracture instability in treated vertebrae (short-term, patient-reported improvement; longer-term durability not reported). - Why It Matters
Vertebral compression fractures and chronic spinal pain are recognized complications of SCD-related osteonecrosis and marrow changes. This case suggests kyphoplasty may be a feasible option for selected patients whose symptoms persist despite conservative management, but evidence remains limited to a single-case report.
- Evidence Gaps & Limitations
This is a single-case report without long-term follow-up or comparative controls. Safety, durability of pain relief, functional outcomes, and optimal patient-selection criteria remain uncertain and require further study in larger SCD populations.
Source: Journal of Sickle Cell Disease- “Kyphoplasty for Vertebral Body Fractures in Sickle Cell Hemoglobinopathy: Case Report”
Regulatory & Guideline Watch
Current American Society of Hematology guidance focuses on medical, rehabilitation, and multidisciplinary pain-management approaches for SCD. Kyphoplasty is not specifically discussed in the guidelines, reflecting the limited evidence currently available for procedural management of vertebral fractures in this population.